Heterogeneous effects of hospital competition on inpatient quality: an analysis of five common diseases in China
Many countries has introduced pro-competition policies in the delivery of healthcare to improve medical quality, including China. With the increasing intensity of competition in China's healthcare market, ther... (Source: Health Economics Review)
Source: Health Economics Review - April 13, 2024 Category: Health Management Authors: Yinghui Lu, Qingling Jiang, Xueli Zhang, Xiaojun Lin and Jay Pan Tags: Research Source Type: research
A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations
ConclusionsMUDMs would improve on current decision support regarding cost-effectiveness information. Given feasibility challenges, this would be most relevant for diseases with multiple treatments, large burden of disease and requiring more complex models. The current overview offers policy makers a starting point to organize the development, use, and maintenance of MUDMs and to support choices concerning which diseases and policy decisions they will be helpful for. (Source: PharmacoEconomics)
Source: PharmacoEconomics - April 13, 2024 Category: Health Management Source Type: research
Addendum
J Med Econ. 2024 Jan-Dec;27(1):605. doi: 10.1080/13696998.2024.2340918. Epub 2024 Apr 12.NO ABSTRACTPMID:38607231 | DOI:10.1080/13696998.2024.2340918 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - April 12, 2024 Category: Health Management Source Type: research
Exploring kidney dialysis costs in the United States: a scoping review
CONCLUSIONS: These findings indicate that prevention of or delay in progression to ESRD could have considerable cost savings for Medicare and private payers, particularly in patients with high-risk conditions such as type 2 diabetes. More efficient use of resources is needed, including low-cost medication, to improve clinical outcomes and lower overall costs, especially in high-risk groups. Widening access to PD where it is safe and appropriate may help to reduce dialysis costs.PMID:38605648 | DOI:10.1080/13696998.2024.2342210 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - April 12, 2024 Category: Health Management Authors: Fiona Stewart Kristin Kistler Yuxian Du Rakesh R Singh Bonnie B Dean Sheldon X Kong Source Type: research
Addendum
J Med Econ. 2024 Jan-Dec;27(1):605. doi: 10.1080/13696998.2024.2340918. Epub 2024 Apr 12.NO ABSTRACTPMID:38607231 | DOI:10.1080/13696998.2024.2340918 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - April 12, 2024 Category: Health Management Source Type: research
Exploring kidney dialysis costs in the United States: a scoping review
CONCLUSIONS: These findings indicate that prevention of or delay in progression to ESRD could have considerable cost savings for Medicare and private payers, particularly in patients with high-risk conditions such as type 2 diabetes. More efficient use of resources is needed, including low-cost medication, to improve clinical outcomes and lower overall costs, especially in high-risk groups. Widening access to PD where it is safe and appropriate may help to reduce dialysis costs.PMID:38605648 | DOI:10.1080/13696998.2024.2342210 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - April 12, 2024 Category: Health Management Authors: Fiona Stewart Kristin Kistler Yuxian Du Rakesh R Singh Bonnie B Dean Sheldon X Kong Source Type: research
Addendum
J Med Econ. 2024 Jan-Dec;27(1):605. doi: 10.1080/13696998.2024.2340918. Epub 2024 Apr 12.NO ABSTRACTPMID:38607231 | DOI:10.1080/13696998.2024.2340918 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - April 12, 2024 Category: Health Management Source Type: research
Exploring kidney dialysis costs in the United States: a scoping review
CONCLUSIONS: These findings indicate that prevention of or delay in progression to ESRD could have considerable cost savings for Medicare and private payers, particularly in patients with high-risk conditions such as type 2 diabetes. More efficient use of resources is needed, including low-cost medication, to improve clinical outcomes and lower overall costs, especially in high-risk groups. Widening access to PD where it is safe and appropriate may help to reduce dialysis costs.PMID:38605648 | DOI:10.1080/13696998.2024.2342210 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - April 12, 2024 Category: Health Management Authors: Fiona Stewart Kristin Kistler Yuxian Du Rakesh R Singh Bonnie B Dean Sheldon X Kong Source Type: research
Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model
ConclusionIf there is reason to believe that margins are regressive, confidential wholesale margins are expected to be better estimated by the power function based on margins of regulated countries than by the published country-specific average margins, reducing significantly inaccurate effects on margin estimations of high-price drugs. (Source: Health Economics Review)
Source: Health Economics Review - April 12, 2024 Category: International Medicine & Public Health Source Type: research
Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model
Based on the legal framework laid down in section 130b (9) of Book V of the German Social Code, various criteria are relevant for the negotiated price for new patented drugs in Germany. European reference pric... (Source: Health Economics Review)
Source: Health Economics Review - April 12, 2024 Category: Health Management Authors: Iris an der Heiden, Guido Schiffhorst, Laura M üller, Martin Albrecht, Arne Bartol and Stefanie Wiberny Tags: Research Source Type: research
Socioeconomic determinants of COVID-19 vaccine acceptance
AbstractThe aim of the paper is to evaluate the relative importance of the set of socioeconomic characteristics of population on collective decision on COVID-19 vaccine acceptance. We apply cross-section OLS methods to the municipal-level non-survey data for 145 municipalities in Serbia, on the COVID-19 vaccination rate and socioeconomic characteristics of the population, to evaluate the determinants of cross-municipal variation in vaccine uptake decision. Using the estimated coefficients from the OLS regressions, we apply the standardized beta method to evaluate the relative importance of each factor. Vaccine acceptance i...
Source: International Journal of Health Care Finance and Economics - April 12, 2024 Category: Health Management Source Type: research
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder
Conclusions: This study found that AEs occurring during ADHD treatment episodes are associated with significant healthcare costs. This highlights the potential of treatments with favorable safety profiles to alleviate the burden experienced by patients and the healthcare system.PMID:38602691 | DOI:10.1080/13696998.2024.2342749 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - April 11, 2024 Category: Health Management Authors: Jeff Schein Martin Cloutier Rebecca Bungay Marjolaine Gauthier-Loiselle Ann Childress Source Type: research
